This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Galectin
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
== Function == | == Function == | ||
| - | '''Galectin''' (GAL) are lectins which bind β-galactosidase (BGAL). GAL contains a carbohydrate recognition domain (CRD)<ref>PMID:8063692</ref>. <br /> | + | '''Galectin''' (GAL) are lectins which bind β-galactosidase (BGAL). GAL contains a carbohydrate recognition domain (CRD) residues 113-250<ref>PMID:8063692</ref>. <br /> |
* GAL-1 is thought to play a role as autocrine negative growth factor that regulates cell proliferation.<br /> | * GAL-1 is thought to play a role as autocrine negative growth factor that regulates cell proliferation.<br /> | ||
* GAL-2 is expressed primarily in gastrointestinal tract.<br /> | * GAL-2 is expressed primarily in gastrointestinal tract.<br /> | ||
* GAL-3 has broad biological functionality.<br /> | * GAL-3 has broad biological functionality.<br /> | ||
* GAL-4 has 2 CRDs.<br /> | * GAL-4 has 2 CRDs.<br /> | ||
| + | * GAL-5 is found in rat is a β-galactoside binding lectin<ref>PMID:19903899</ref>.<br /> | ||
* GAL-7 is associated with epithelial cells.<br /> | * GAL-7 is associated with epithelial cells.<br /> | ||
* GAL-8 has a role in cellular defense against bacterial infection and vacuolar damage.<br /> | * GAL-8 has a role in cellular defense against bacterial infection and vacuolar damage.<br /> | ||
* GAL-9 affects eosinophil survival. <br /> | * GAL-9 affects eosinophil survival. <br /> | ||
| - | * GAL-10 or Charcot-Leyden crystal protein acts on biological membranes to regulate the multifunctional lysophospholipids. | + | * GAL-10 or Charcot-Leyden crystal protein acts on biological membranes to regulate the multifunctional lysophospholipids.<br /> |
| + | * GAL-13 is a placental protein which does not bind β-galactosides.<br /> | ||
== Relevance == | == Relevance == | ||
| Line 36: | Line 38: | ||
**[[1w6o]], [[2zkn]] – hGAL-1 (mutant) + lactose<br /> | **[[1w6o]], [[2zkn]] – hGAL-1 (mutant) + lactose<br /> | ||
**[[4q26]], [[4q27]], [[4xbl]] - hGAL-1 + acetyl lactosamine<br /> | **[[4q26]], [[4q27]], [[4xbl]] - hGAL-1 + acetyl lactosamine<br /> | ||
| - | **[[4y1u]], [[4y1v]], [[4y1x]], [[4y1y]], [[4y1z]], [[4y20]], [[4y22]], [[4y24]] - hGAL-1 N-terminal + Gal-GlcNac<br /> | ||
**[[1w6p]] – hGAL-1 (mutant) + acetyl lactosamine<br /> | **[[1w6p]] – hGAL-1 (mutant) + acetyl lactosamine<br /> | ||
| + | **[[4y1u]], [[4y1v]], [[4y1x]], [[4y1y]], [[4y1z]], [[4y20]], [[4y22]], [[4y24]] - hGAL-1 N-terminal + Gal-GlcNac<br /> | ||
**[[1gzw]] – hGAL-1 + BGAL<br /> | **[[1gzw]] – hGAL-1 + BGAL<br /> | ||
**[[1w6m]] – hGAL(mutant) + BGAL<br /> | **[[1w6m]] – hGAL(mutant) + BGAL<br /> | ||
| Line 43: | Line 45: | ||
**[[3oyw]] - hGAL-1 + thio-digalactoside<br /> | **[[3oyw]] - hGAL-1 + thio-digalactoside<br /> | ||
**[[3t2t]], [[4q1p]], [[4q1r]], [[4q2f]] – hGAL-1 + inhibitor<br /> | **[[3t2t]], [[4q1p]], [[4q1r]], [[4q2f]] – hGAL-1 + inhibitor<br /> | ||
| + | **[[5mwt]], [[5mwx]] – hGAL-1 + ligand<br /> | ||
**[[1gan]] – tGAL-1 + BGAL – toad<br /> | **[[1gan]] – tGAL-1 + BGAL – toad<br /> | ||
**[[1a78]] – tGAL-1 + thio-digalactose<br /> | **[[1a78]] – tGAL-1 + thio-digalactose<br /> | ||
| Line 61: | Line 64: | ||
*Galectin-3 | *Galectin-3 | ||
| - | **[[3zsk]], [[3zsl]], [[3zsm]] – hGAL-3 CRD<br /> | + | **[[3zsk]], [[3zsl]], [[3zsm]], [[5nlc]] – hGAL-3 CRD<br /> |
| + | **[[6f2q]] - hGAL-3 CRD – neutron<br /> | ||
**[[1a3k]], [[1kjl]], [[2nmn]] – hGAL-3 CRD + BGAL<br /> | **[[1a3k]], [[1kjl]], [[2nmn]] – hGAL-3 CRD + BGAL<br /> | ||
**[[2nmo]] - hGAL-3 CRD + glucose + BGAL<br /> | **[[2nmo]] - hGAL-3 CRD + glucose + BGAL<br /> | ||
**[[2nn8]], [[3aye]], [[3zsj]], [[4r9a]], [[4r9b]], [[4r9c]], [[4r9d]], [[4rl7]] - hGAL-3 CRD + lactose<br /> | **[[2nn8]], [[3aye]], [[3zsj]], [[4r9a]], [[4r9b]], [[4r9c]], [[4r9d]], [[4rl7]] - hGAL-3 CRD + lactose<br /> | ||
| - | **[[1kjr ]], [[4xbn]] – hGAL-3 CRD + | + | **[[1kjr ]], [[4xbn]], [[5nf7]], [[5nf9]], [[5nla]], [[5nlb]] – hGAL-3 CRD + lactosamine derivative<br /> |
**[[2xg3]], [[3t1l]], [[3t1m]], [[5e88]], [[5e89]], [[5e8a]], [[5exo]], [[5h9p]], [[5h9r]], [[5iuq]] - hGAL-3 CRD + inhibitor<br /> | **[[2xg3]], [[3t1l]], [[3t1m]], [[5e88]], [[5e89]], [[5e8a]], [[5exo]], [[5h9p]], [[5h9r]], [[5iuq]] - hGAL-3 CRD + inhibitor<br /> | ||
**[[3aya]] - hGAL-3 CRD + antigen<br /> | **[[3aya]] - hGAL-3 CRD + antigen<br /> | ||
**[[3ayc]], [[3ayd]], [[4jc1]], [[4jck]] - hGAL-3 CRD + polysaccharide<br /> | **[[3ayc]], [[3ayd]], [[4jc1]], [[4jck]] - hGAL-3 CRD + polysaccharide<br /> | ||
**[[4lbj]], [[4lbk]], [[4lbl]], [[4lbm]], [[4lbn]], [[4lbo]] - hGAL-3 CRD (mutant) + glycosphingolipid<br /> | **[[4lbj]], [[4lbk]], [[4lbl]], [[4lbm]], [[4lbn]], [[4lbo]] - hGAL-3 CRD (mutant) + glycosphingolipid<br /> | ||
| - | **[[4bli]], [[4blj]], [[4bm8]] - hGAL-3 CRD + thiogalactoside derivative<br /> | + | **[[4bli]], [[4blj]], [[4bm8]], [[5oax]], [[5ody]] - hGAL-3 CRD + thiogalactoside derivative<br /> |
*Galectin-4 | *Galectin-4 | ||
| Line 81: | Line 85: | ||
**[[2dyc]] – mGAL-4 CRD <br /> | **[[2dyc]] – mGAL-4 CRD <br /> | ||
**[[3i8t]] – mGAL-4 + lactose<br /> | **[[3i8t]] – mGAL-4 + lactose<br /> | ||
| + | |||
| + | *Galectin-5 | ||
| + | |||
| + | **[[5jp5]] – rGAL-5<br /> | ||
| + | **[[5jpg]] – rGAL-5 + lactose<br /> | ||
*Galectin-7 | *Galectin-7 | ||
| Line 109: | Line 118: | ||
**[[5t7t]] – hGAL-8 N terminal (mutant) + LNT<br /> | **[[5t7t]] – hGAL-8 N terminal (mutant) + LNT<br /> | ||
**[[2yy1]] – hGAL-8 N terminal + acetyllactosamine<br /> | **[[2yy1]] – hGAL-8 N terminal + acetyllactosamine<br /> | ||
| + | **[[5vwg]] – hGAL-8 N terminal (mutant) + galactopyranoside derivative<br /> | ||
**[[4wvv]], [[4wvw]] - cGAL-8 N terminal + lactose derivative<br /> | **[[4wvv]], [[4wvw]] - cGAL-8 N terminal + lactose derivative<br /> | ||
| Line 118: | Line 128: | ||
**[[2d6p]] – mGAL-9 CRD + antigen<br /> | **[[2d6p]] – mGAL-9 CRD + antigen<br /> | ||
**[[3lsd]] – hGAL-9 N terminal<br /> | **[[3lsd]] – hGAL-9 N terminal<br /> | ||
| - | **[[3wv6]] – hGAL (mutant)<br /> | + | **[[3wv6]] – hGAL-9 (mutant)<br /> |
**[[3nv1]] – hGAL-9 CRD<br /> | **[[3nv1]] – hGAL-9 CRD<br /> | ||
**[[3lse]] – hGAL-9 N terminal + lactose<br /> | **[[3lse]] – hGAL-9 N terminal + lactose<br /> | ||
| Line 129: | Line 139: | ||
*Galectin-10 | *Galectin-10 | ||
| + | **[[5xrg]], [[5xrh]] – hGAL-10 <br /> | ||
| + | **[[5yt4]], [[5xri]], [[5xrj]], [[5xrk]], [[5xrl]], [[5xrm]], [[5xrn]], [[5xro]], [[5xrp]] – hGAL-10 (mutant)<br /> | ||
**[[1bkz]] – hGAL-10 + mannose<br /> | **[[1bkz]] – hGAL-10 + mannose<br /> | ||
**[[1hdk]] – hGAL-10 + PCMBS | **[[1hdk]] – hGAL-10 + PCMBS | ||
| + | |||
| + | *Galectin-13 or galactoside-binding soluble lectin 13 | ||
| + | |||
| + | **[[5xg7]] – hGAL-13 <br /> | ||
| + | **[[5y03]], [[5xg9]] – hGAL-13 (mutant)<br /> | ||
*Galectin | *Galectin | ||
| Line 140: | Line 157: | ||
**[[4hl0]], [[5glt]], [[5glu]], [[5glv]], [[5glw]], [[5glz]], [[5gm0]] – GAL – ''Toxascaris leonina''<br /> | **[[4hl0]], [[5glt]], [[5glu]], [[5glv]], [[5glw]], [[5glz]], [[5gm0]] – GAL – ''Toxascaris leonina''<br /> | ||
**[[3wuc]], [[3wud]] – GAL – ''Xenopus laevis''<br /> | **[[3wuc]], [[3wud]] – GAL – ''Xenopus laevis''<br /> | ||
| + | **[[5nld]], [[5nle]], [[5nlh]], [[5nlz]], [[5nm1]], [[5nm6]], [[5nmj]] – cGAL + lactose<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:12, 29 May 2018
| |||||||||||
3D structures of galectin
Updated on 29-May-2018
